Kleanthis G. Xanthopoulos's most recent trade in Connect Biopharma Holdings Ltd - ADR was a trade of 3,738 Ordinary Shares done . Disclosure was reported to the exchange on June 30, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Connect Biopharma Holdings Ltd (ADR) | Kleanthis G. Xanthopoulos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2026 | 3,738 | 86,554 | - | 0 | Ordinary Shares | |
| Connect Biopharma Holdings Ltd (ADR) | Kleanthis G. Xanthopoulos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2026 | 2,816 | 82,816 | - | 0 | Ordinary Shares |